Media Partners




3月11日(一) 5:00 - 6:00PM

5:15 Biospecimen Donation: Personal Journey of a Family and Genetic Diagnostic Lab Advancing Biomedical Research
Sarah shares the now world-famous story of how she anonymously donated her infant son’s post-mortem tissue for biomedical research to some of the most prestigious scientific facilities in the country, including the University of Pennsylvania. Years later, she tracked down each donation. She met with researchers and scientists who received the donations to learn how they are being studied in cutting-edge research for medical discoveries. One of these research scientists who received her son’s retinas is Dr. Arupa Ganguly. Dr. Ganguly directs the genetic diagnostic lab at the University of Pennsylvania and studies retinoblastoma, a childhood-onset cancer caused by mutations in tumor suppression gene. They will share their experience and perspective on biospecimen donation.

Gray_SarahSarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science 
Ganguly_ArupaArupa Ganguly, PhD, Professor of Genetics, Perelman School of Medicine, University of Pennsylvania

Speaker to be Announced, Rheonix

6:00 Grand Opening Reception in the Exhibit Hall with Poster Viewing and Book Signing*

*Book Signing with Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
Book will be available for purchase onsite

3月12日(二) 8:00 - 9:15AM

Data Science Enabling Personalized Medicine

Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide datasets. But the question remains: is it enough to train smarter algorithms with broader datasets? What other approaches, diagnostics tools, and technologies do we need to accurately assess a patient’s unique needs and build a personalized intervention? A panel of experts across diagnostics, informatics, and therapeutics from government, academia, integrated health centers, data science, and biopharma will lead a highly interactive exploration of these issues and predict what it will take to realize the role of data science enabling personalized medicine.

Moderator: Marty Tenenbaum, PhD, Founder and Chairman, Cancer Commons; Prominent AI Researcher; Cancer Survivor


Tanya CashoraliTanya Cashorali, CEO, Founder, TCB Analytics

Kaushik_GauravGaurav Kaushik, Associate Director, Data Products & Strategy, Foundation Medicine, Inc.

David SmoleyDavid Smoley, CIO, AstraZeneca

Additional Speakers to be Announced

3月13日(三) 8:00 - 10:00AM

Plenary Session Panel: Emerging Technologies and Industry Perspectives

A popular session at Tri-Conference! This panel session will feature a series of short podium presentations on emerging and hot technologies in molecular medicine. Each speaker will have 7 minutes to present. After all speakers have presented, there will be a moderated Q&A with attendees. The presentations are not meant to be a corporate or specific product pitch. Each speaker will focus on a technology and solution framed around a motivational clinical problem and how their particular company/organization is solving it.


Kristin Ciriello Pothier, Global Head of Life Sciences Strategy, Parthenon-EY; Author, Personalizing Precision Medicine

Scott Palmer, Vice President and Head of Precision Medicine, Parthenon-EY


Speaker to be Announced, Protolife

Speaker to be Announced, iSpecimen

Speaker to be Announced, Ximedica

Joseph KruegerJoseph Krueger, CSO, Flagship Biosciences

Florian Bell, Senior Member, Technical Staff-System Integration, Qorvo Biotechnologies, LLC

Speaker to be Announced, Benchling

Speaker to be Announced, ANGLE plc

Additional Speakers to be Announced

* 活動內容有可能不事先告知作更動及調整。

Choose your language